Wire Stories
-
767Kamigumi Selects Rimini Street Support for Its SAP Applications
Leading Japanese transportation and logistics company avoids costly, no ROI migration to S/4HANA; redirects savings into strategic IoT and security initiatives LAS...
-
708
Baxter Receives CE Marking and Australian Regulatory Approval for Evo IQ Syringe Infusion System, Building on Smart Pump Platform
New addition to Baxter’s Evo IQ Infusion Platform complements on-market large volumetric pump, offering opportunity to further help personalize treatment Incorporates web-based...
-
759
CyberLink Partners With Advantech to Enable FaceMe� Facial Recognition for Retail, Hospitality and Security AIoT Applications
The partnership will integrate FaceMe® facial recognition in the new FaceView app for visitor identification and analysis TAIPEI, Taiwan–(BUSINESS WIRE)–#CyberLink—CyberLink Corp. (5203.TW),...
-
719
The NAGA Group announces challenger bank project NAGA Pay. NAGA China and NAGA Pro are launched, supported by strong April figures.
The challenger bank project NAGA PAY starts in Q4 2020 Trading influencer tool NAGA Pro launched Strong April with sales of €...
-
826
Genetron Health Announces Strategic Collaboration with DARUI on GENETRON S5 Platform
BEIJING–(BUSINESS WIRE)–Genetron Holdings Limited (“Genetron Health”), a China-based precision oncology company that covers full-cycle cancer care, announced that it has joined forces...
-
691
New Research From DocsCorp Shows Enterprise Software Investment Will Continue, Despite the COVID-19 Crisis
500 people in the U.S. were asked if upgrading or purchasing new enterprise software was a priority at a time when businesses...
-
696
New Frontier Healthcare to Announce First Quarter of 2020 Financial Results on May 27, 2020
BEIJING–(BUSINESS WIRE)–New Frontier Health Corporation (“NFH” or “the Company”) (NYSE: NFH), operator of the premium healthcare services provider United Family Healthcare (UFH),...
-
723
IQVIA Collaborates with Australian Medical Research Institute on COVID-19 Study to Support Frontline Healthcare Workers
Randomized, double-blind clinical study will test Hydroxychloroquine as a prophylactic treatment to prevent high-risk healthcare workers from contracting COVID-19 DANBURY, Conn. &...
-
729
Rising Pharmaceuticals to Support Phase 2 Clinical Trial of Chloroquine Phosphate for Prophylaxis Against COVID-19 in Healthcare Workers at Risk for COVID-19
Trial conducted at Columbia University will investigate potential of chloroquine phosphate to prevent symptomatic SARS-CoV-2 infections EAST BRUNSWICK N.J.–(BUSINESS WIRE)–Rising Pharma Holdings...
-
700
Asia-Pacific Hand Sanitizer Market Assessment 2020-2025: Anticipated to be Worth $2.64 Billion at the End of 2025 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Asia-Pacific Hand Sanitizer Market Outlook, 2025” report has been added to ResearchAndMarkets.com’s offering. The Asia-Pacific Hand sanitizer market is expected...
